A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
This study has been completed.
Sponsor:
Eli Lilly and Company
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00642018
First received: February 28, 2008
Last updated: May 24, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2012 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | May 24, 2012 |